SEC Form 4 · accession 0001144204-17-034642
Alliqua BioMedical, Inc. · ALQA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bradford Barton
Officer — Chief Operating Officer
Period of report
Jun 28, 2017
Accepted (ET)
Jun 28, 2017 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001054274
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 28, 2017 | A | 100,000 | $0.00 | A | 626,358 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a restricted stock award that is subject to forfeiture until vested. The award vests fully on the date, if any, the Issuer files financial statements with the SEC on Form 10-K or Form 10-Q that report a positive adjusted EBITDA for the Company for two consecutive fiscal quarters, subject to the Reporting Person's continued service through the applicable vesting date and the terms and conditions of the Alliqua BioMedical, Inc. 2014 Long-Term Incentive Plan and that certain restricted stock award agreement by and between the Issuer and the Reporting Person, effective as of June 28, 2017.